[DNA polymorphism, allogenic bone marrow transplantation and peripheral cell chimerism]

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Context:

• Bone marrow and peripheral stem cell transplantation are effective treatments for various diseases.
• Advancements in molecular diagnostics allow for precise monitoring of graft engraftment and post-transplantation progression.
• Tracking minimal residual disease is crucial for successful patient outcomes.

Purpose:

• To evaluate the efficacy of molecular diagnostic methods in monitoring chimerism post-transplantation.
• To analyze the kinetics of donor cell engraftment and chimerism status in patients.
• To differentiate between disease relapse and true hematologic recovery using chimerism analysis.

Summary:

• Molecular techniques, including PCR and restriction analysis, were used to genotype specific loci in patients' peripheral blood.
• Early signs of donor bone marrow activity were observed within two weeks in 50% of patients.
• Complete chimerism was achieved in approximately 50% of patients, while others exhibited mixed chimerism (donor and recipient cells).
• Chimerism monitoring effectively distinguished between disease relapse and hematopoietic recovery in oncohematologic patients.
• Regression of mixed chimerism was observed, potentially due to treatment or spontaneous processes.

Impact:

• Molecular monitoring of chimerism provides critical information for guiding treatment decisions in transplant patients.
• Integrating molecular chimerism examination into patient care is essential for optimizing post-transplantation management.
• This approach enhances the understanding of engraftment dynamics and treatment response, improving patient prognoses.